Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 2 |
Apple
AAPL
|
+$949M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$788M |
| 4 |
Microsoft
MSFT
|
+$654M |
| 5 |
Broadcom
AVGO
|
+$568M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.26B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$702M |
| 3 |
Tesla
TSLA
|
+$694M |
| 4 |
Micron Technology
MU
|
+$601M |
| 5 |
Strategy Inc
MSTR
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.3% |
| 2 | Technology | 1.97% |
| 3 | Financials | 0.89% |
| 4 | Consumer Discretionary | 0.83% |
| 5 | Healthcare | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
PUT
WD-40
WDFC
$2.91B
| $3.37M | ﹤0.01% |
13,900
-17,900
| -56% | -$4.77M |
|
4252
Hims & Hers Health
HIMS
$6.73B
| $3.37M | ﹤0.01% |
139,502
-1,216,699
| -90% | -$30.1M |
|
4253
Vuzix
VUZI
$219M
| $3.37M | ﹤0.01% |
855,653
+592,115
| +225% | +$1.21M |
|
4254
PUT
Magnite
MGNI
$3.4B
| $3.37M | ﹤0.01% |
211,600
+80,000
| +61% | +$1.17M |
|
4255
Banco Bradesco
BBD
$34.4B
| $3.37M | ﹤0.01% |
1,763,577
-27,830
| -2% | -$65.2K |
|
4256
CALL
Arcutis Biotherapeutics
ARQT
$2.99B
| $3.36M | ﹤0.01% |
241,500
+61,500
| +34% | +$674K |
|
4257
iShares Latin America 40 ETF
ILF
$3.72B
| $3.36M | ﹤0.01% |
160,473
+115,415
| +256% | +$2.77M |
|
4258
JPMorgan BetaBuilders Emerging Markets Equity ETF
BBEM
$849M
| $3.35M | ﹤0.01% |
+65,622
| New | +$3.53M |
|
4259
CALL
Primoris Services
PRIM
$3.94B
| $3.35M | ﹤0.01% |
43,800
+19,100
| +77% | +$1.4M |
|
4260
Keros Therapeutics
KROS
$219M
| $3.35M | ﹤0.01% |
211,309
+202,261
| +2,235% | +$10.5M |
|
4261
PUT
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
| $3.34M | ﹤0.01% |
13,900
-9,800
| -41% | -$2.41M |
|
|
LB
4262
PUT
LandBridge Co
LB
$2.47B
| $3.34M | ﹤0.01% |
+51,700
| New | +$3.11M |
|
4263
PUT
Blue Bird Corp
BLBD
$1.88B
| $3.34M | ﹤0.01% |
86,400
+24,800
| +40% | +$1.04M |
|
4264
CALL
Evolent Health
EVH
$520M
| $3.34M | ﹤0.01% |
296,600
+99,900
| +51% | +$1.76M |
|
4265
Essent Group
ESNT
$6.19B
| $3.34M | ﹤0.01% |
61,269
+46,591
| +317% | +$2.7M |
|
4266
PUT
LGI Homes
LGIH
$1.34B
| $3.33M | ﹤0.01% |
37,300
-20,700
| -36% | -$2.17M |
|
|
QXO
4267
PUT
QXO Inc
QXO
$14B
| $3.33M | ﹤0.01% |
209,700
-108,200
| -34% | -$1.7M |
|
|
SILV
4268
PUT
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $3.33M | ﹤0.01% |
366,300
-55,700
| -13% | -$564K |
|
|
GEAR
4269
PUT
DELISTED
Revelyst, Inc.
GEAR
| $3.33M | ﹤0.01% |
+173,300
| New | +$3.3M |
|
4270
Alkermes
ALKS
$7.95B
| $3.33M | ﹤0.01% |
115,707
-37,104
| -24% | -$1.07M |
|
4271
Organon & Co
OGN
$3.61B
| $3.33M | ﹤0.01% |
222,994
+185,096
| +488% | +$3.02M |
|
4272
Tiptree Inc
TIPT
$687M
| $3.33M | ﹤0.01% |
159,492
+134,534
| +539% | +$2.82M |
|
4273
CALL
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.19B
| $3.33M | ﹤0.01% |
107,700
+81,400
| +310% | +$2.53M |
|
4274
CALL
Stride
LRN
$3.61B
| $3.33M | ﹤0.01% |
32,000
-51,300
| -62% | -$4.88M |
|
4275
CALL
Agree Realty
ADC
$9.1B
| $3.33M | ﹤0.01% |
47,200
-19,200
| -29% | -$1.43M |
|
Similar funds
Jeff Yass's Q4 2024 Portfolio in Review
As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q4 2024 filing shows 1,862 new, 5,386 increased, 4,790 reduced and 1,590 closed positions. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 94% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
- Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
- Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
- Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
- Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.